Showing results (281-290 of 618) with videos related to

Sort By:
Pageof 62
Neuro-Oncology|September 6, 2014
Immunotherapy advances for glioblastomaDavid A Reardon, Gordon Freeman, Catherine Wu, et al.
Neuro-Oncology Advances|May 22, 2023
An expanded role for surgery in grade 3 1p/19q co-deleted oligodendrogliomaSaksham Gupta, Noah L Nawabi, Siva Emani, et al.
Cancer Research|December 1, 2011
Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusionA Gregory Sorensen, Kyrre E Emblem, Pavlina Polaskova, et al.
Neurosurgery|May 20, 2011
Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working GroupMichael A Vogelbaum, Sarah Jost, Manish K Aghi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2009
Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q lossMatija Snuderl, April F Eichler, Keith L Ligon, et al.
Neuro-Oncology|September 25, 2016
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastomaTracy T Batchelor, Elizabeth R Gerstner, Xiaobu Ye, et al.
Neuro-Oncology|February 22, 2024
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohortYazmin Odia, Matthew D Hall, Timothy Francis Cloughesy, et al.
Neuro-Oncology|August 8, 2014
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningiomaThomas J Kaley, Patrick Wen, David Schiff, et al.
Neuro-Oncology|November 9, 2019
Biological activity of weekly ONC201 in adult recurrent glioblastoma patientsIsabel Arrillaga-Romany, Yazmin Odia, Varun V Prabhu, et al.
Neuro-Oncology|May 29, 2015
Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade gliomaPatrick Y Wen, Antonio Omuro, Manmeet S Ahluwalia, et al.
Pageof 62